Philips announces SpectraWAVE acquisition, expanding intravascular imaging portfolio

Philips has agreed to acquire SpectraWAVE, a Massachusetts-based medical device company focused on technologies to help diagnose and guide treatment for patients with coronary artery disease. SpectraWAVE’s technology specialises in advancing intravascular imaging and physiological assessment with AI. This acquisition positions Philips at the intersection of diagnostic imaging, cardiovascular health, and AI-driven healthcare. This acquisition will strengthen Philips’ presence in the intravascular imaging, p ...